Citation Impact
Citing Papers
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Other relevant components of nuts: phytosterols, folate and minerals
2006
Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men
2004
Bound phenolics in foods, a review
2013 Standout
Bowel Disorders
2016 Standout
Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: Increased atherogenicity for the metabolic syndrome
2006
Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
2010
Microbial xylanases and their industrial applications: a review
2001
Contribution of Primary Care to Health Systems and Health
2005 Standout
Evidence‐Based Medicine, Heterogeneity of Treatment Effects, and the Trouble with Averages
2004
Hepatic Insulin Resistance Is Sufficient to Produce Dyslipidemia and Susceptibility to Atherosclerosis
2008
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
2011
Feruloyl Esterases as Biotechnological Tools: Current and Future Perspectives
2007
Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage
2004
A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
2011
Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data
2015
Xylanases from fungi: properties and industrial applications
2005 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Health Benefits of Nut Consumption
2010 Standout
Conversion of Biomass into Chemicals over Metal Catalysts
2013 Standout
The Metabolic Syndrome
2008 Standout
Modeling and Scale-up of Sitosterol Hydrogenation Process: From Laboratory Slurry Reactor to Plant Scale
2006
Works of F.H. O’Neill being referenced
Rapid and simple assay for feruloyl and p-coumaroyl esterases
1996
Modification of the Carbohydrate Composition of Sulfite Pulp by Purified and Characterized β-Xylanase and β-Xylosidase of Aureobasidium pullulans
1999
Plasma Markers of Cholesterol Homeostasis and Apolipoprotein B‐100 Kinetics in the Metabolic Syndrome
2003
Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism
2004
Effect of inhibiting HMG‐CoA reductase on 7α‐hydroxy‐4‐cholesten‐3‐one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up‐regulation of the latter pathway
1999
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome
2003
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome
2003
Comparison of Efficacy of Plant Stanol Ester and Sterol Ester: Short-Term and Longer-Term Studies
2005
Screening for Dysbetalipoproteinemia by Plasma Cholesterol and Apolipoprotein B Concentrations
2005
Determinants of Variable Response to Statin Treatment in Patients With Refractory Familial Hypercholesterolemia
2001